Samsung Biologics plans to set up holding company to separate CDMO, biosimilar biz
Seoul, May 22 (IANS) Samsung Biologics, a biotech arm of South Korea’s Samsung Group, on Thursday said it plans to spin off its biosimilar development business to streamline its operations… Continue reading Samsung Biologics plans to set up holding company to separate CDMO, biosimilar biz







